Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.

Davidson, M H; Maki, K C; Marx, P; Maki, A C; Cyrowski, M S; Nanavati, N; Arce, J C

Davidson, M H; Maki, K C; Marx, P; Maki, A C; Cyrowski, M S; Nanavati, N; Arce, J C.

Affiliation

Davidson MH; Nutrition and Metabolism Research Unit, Chicago Center for Clinical Research, 515 N State St, 27th Floor, Chicago, IL 60610, USA.

Arch Intern Med ; 160(21): 3315-25, 2000 Nov 27.

Article in En | MEDLINE | ID: mdl-11088095

Subject(s)

Cardiovascular Diseases/etiology; Cardiovascular Diseases/prevention & control; Estradiol/administration & dosage; Estrogen Replacement Therapy; Lipids/blood; Norethindrone/administration & dosage; Postmenopause/blood; Aged; Apolipoprotein A-I/blood; Blood Coagulation Factors/metabolism; Blood Glucose/metabolism; C-Peptide/blood; Cholesterol, HDL/blood; Cholesterol, LDL/blood; Double-Blind Method; Drug Administration Schedule; Female; Glycated Hemoglobin/metabolism; Humans; Insulin/blood; Lipoprotein(a)/blood; Middle Aged; Norethindrone/analogs & derivatives; Norethindrone Acetate; Risk Factors; Treatment Outcome; Triglycerides/blood

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Estrogen Replacement Therapy / Postmenopause / Estradiol / Lipids / Norethindrone Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Arch Intern Med Year: 2000 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links